Skrbic_2017_Basic.Clin.Pharmacol.Toxicol_120_615

Reference

Title : Naloxone Antagonizes Soman-induced Central Respiratory Depression in Rats - Skrbic_2017_Basic.Clin.Pharmacol.Toxicol_120_615
Author(s) : Skrbic R , Stojiljkovic MP , Cetkovic SS , Dobric S , Jeremic D , Vulovic M
Ref : Basic Clin Pharmacol Toxicol , 120 :615 , 2017
Abstract :

The influence of naloxone on respiration impaired by the highly toxic organophosphate nerve agent soman in anaesthetized rats was investigated. Soman, administered in a dose that was ineffective in blocking the electrically induced contractions of the phrenic nerve-diaphragm preparation in situ, induced a complete block of the spontaneous respiratory movements of the diaphragm, indicating the domination of central over the peripheral effects. Naloxone dose-dependently antagonized the soman-induced respiratory blockade. Atropine, at a dose that was per se ineffective in counteracting soman-induced respiratory depression, potentiated the protective effects of naloxone and completely restored respiration. Naloxone remained completely ineffective in antagonizing respiratory depression induced by the muscarinic receptor agonist the oxotremorine. It is assumed that naloxone antagonizes soman-induced respiratory inhibition by blocking endogenous opioidergic respiratory control pathways that are independent of the stimulation of muscarinic receptors.

PubMedSearch : Skrbic_2017_Basic.Clin.Pharmacol.Toxicol_120_615
PubMedID: 27992665

Related information

Citations formats

Skrbic R, Stojiljkovic MP, Cetkovic SS, Dobric S, Jeremic D, Vulovic M (2017)
Naloxone Antagonizes Soman-induced Central Respiratory Depression in Rats
Basic Clin Pharmacol Toxicol 120 :615

Skrbic R, Stojiljkovic MP, Cetkovic SS, Dobric S, Jeremic D, Vulovic M (2017)
Basic Clin Pharmacol Toxicol 120 :615